Daily Stock List
Liberated Energy, Inc. (LIBE)
PennyStocks24, Top Stock Tips, and TheMicrocapNews reported earlier on Liberated Energy, Inc. (LIBE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed Liberated Energy, Inc. is an alternative energy company. It looks to reduce the removing of the planet's resources through bringing patentable and affordable ideas to the market. The Company’s initial goal is to make small wind and solar turbine technology a major contributor to the international clean energy supply portfolio. This is through providing consumers with an affordable renewable energy option for their homes and businesses. The Company recently acquired Perpetual Wind Power Corp. (PWPC). Liberated Energy has its corporate headquarters in Marlton, New Jersey.
Liberated Energy has patents pending for a ridgeline roof wind device, and the Guard Lite™. Moreover, it is looking at other alternative energy products that it hopes to seek patents on and commercialize.
The Guard Lite™ employs wind and solar energy to power its security system. The system consists of a High Tech LED Lighting Wi-Fi HD Camera with 2 way audio Infrared and Motion Technology. The Guard Lite™ is self-powered. It will use only approximately 10 percent of its maximum rated wind and solar energy. Excess energy can be used for other electrical components.
In March 2014, Liberated Energy announced that by way of a partnership with Hemp, Inc. (HEMP), it will be expanding its alternative energy technologies into the industrial hemp industry. By working in concert, Hemp and its subsidiaries will be able to provide new gateways of distribution for Liberated Energy's unique Guard Lite™ Security Lighting System and its other patent pending technologies.
Liberated Energy entered into an agreement with Hemp’s “The Industrial Hemp and Medical Marijuana Consulting Company, Inc. “(IHMMCC) to help it market and distribute its alternative energy products in the Industrial Hemp and Medical Marijuana industries.
This past July, Liberated Energy announced that it signed a Letter of Intent (LOI) to Joint Venture with FutureWorld Corp., a top provider of advanced solutions to the Cannabis industry globally with its subsidiary HempTech. This will allow Liberated Energy to integrate CaNNaLyTiX™, SmartSense™, and SmartNergy™ with the Guard Lite™.
Liberated Energy, Inc. (LIBE), closed Friday's trading session at $0.05, even for the day, on 4,000 volume with 1 trade. The average volume for the last 60 days is 336,084 and the stock's 52-week low/high is $0.007/$0.40.
Ekso Bionics Holdings, Inc. (EKSO)
Money Morning, CustomerService, PricelessPennyStocks, PennyStockRumors.net, Weekly Wizards, Actual Gains, PennyStocks24, Pennybuster, InvestorPlace, MonsterStocksPicks, and Stock Stars reported on Ekso Bionics Holdings, Inc. (EKSO), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Richmond, California-based Ekso Bionics Holdings, Inc. designs, develops, and commercializes exoskeletons, or wearable robots. Exoskeletons are ready-to-wear, battery-powered robots. They are strapped over the user's clothing, enabling individuals to achieve mobility, strength, or endurance not otherwise possible. These have a variety of potential applications in the medical, military, industrial, as well as consumer markets. The Company’s lead product is Ekso™. Ekso™ has helped thousands of people living with paralysis take millions of steps not otherwise possible. Ekso Bionics’ shares trade on the OTC Bulletin Board.
The Company’s Ekso™ is a robotic exoskeleton used for the rehabilitation of individuals with lower extremity weakness, paralysis or hemiparesis (weakness on one side of the body) owing to such neurological conditions as stroke, spinal cord injury or disease, and traumatic brain injury. Ekso™ is a wearable bionic suit. It allows individuals with any amount of lower extremity weakness to stand up and walk over ground with a natural, full weight bearing, and reciprocal gait.
Walking is achieved by the user’s weight shifts to activate sensors in the device, which initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function. Ekso Bionics Holdings has been accepted by the Center for Sensorimotor Neural Engineering (CSNE) as an industry partner. Ekso Bionics and CSNE will work together to enrich the human machine interface and enhance potential neural interface to create links between the nervous system and the outside world.
This week, Ekso Bionics Holdings announced that it was awarded a P20 Exploratory Grant from the National Institutes of Health (NIH). This is to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland. This work will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton.
Working with UCSF Benioff Children's Hospital Oakland allows for the effective integration of advanced robotics into a first-rate pediatric rehabilitative practice. UCSF Benioff Children's Hospital Oakland (formerly Children's Hospital & Research Center Oakland) is a leading, not-for-profit medical center for children in Northern California. It is the only hospital in the East Bay 100 percent devoted to pediatrics.
Ekso Bionics Holdings, Inc. (EKSO), closed Friday's trading session at $1.37, down 0.72%, on 221,732 volume with 185 trades. The average volume for the last 60 days is 756,731 and the stock's 52-week low/high is $0.753/$8.22.
HealthWarehouse.com, Inc. (HEWA)
FeedBlitz and SmallCapVoice reported previously on HealthWarehouse.com, Inc. (HEWA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
HealthWarehouse.com, Inc. is a Verified Internet Pharmacy Practice Sites (VIPPS) accredited retail mail-order pharmacy and healthcare e-commerce company. It sells discounted generic and brand name prescription drugs and over-the-counter (OTC) medical products and surgical supplies. The Company’s website addresses are www.healthwarehouse.com and www.hocks.com. HealthWarehouse.com’s goals are to make the pharmaceutical supply chain more efficient and to pass the savings on to the consumer. The Company lists on the OTC Markets’ OTCQB. HealthWarehouse.com is based in Florence, Kentucky.
HealthWarehouse.com offers an industry leading 90-day return policy with no restocking fees. It only sell products which are Food and Drug Administration (FDA) approved and legal in the United States. The Company sells its products directly to the individual consumers of the pharmaceutical and non-pharmaceutical products.
HealthWarehouse.com is fully regulated by the federal government of the United States. Therefore, it must source its drugs from trustworthy FDA approved manufacturers. The Company’s operations center on a state-of-the-art pharmacy that can handle over 5,000 prescriptions daily. HealthWarehouse.com presently services more than 450,000 unique customers. It provides 100 percent free shipping on any order to all 50 states, U.S. Territories, and U.S. Military APO/FPO locations.
HealthWarehouse.com sells a collection of prescription drugs; diabetic supplies, including glucometers, lancets, syringes, and test strips; and OTC medications covering a range of conditions (allergy, sinus, pain, fever, and smoking cessation aids). In addition, it offers home medical supplies, which includes incontinence supplies, first aid kits, and mobility aids; and diet and nutritional products consisting of supplements, weight loss aids, as well as vitamins and minerals.
The Company uses high-quality generic manufacturers. Some of its manufacturers include Teva, Watson, Sandoz, Apotex, Mylan, Dr. Reddy's, and Cobalt. Furthermore, HealthWarehouse.com, being a fully licensed and regulated pharmacy, is able to dispense controlled substances with a valid prescription. However, there are a number of guidelines and regulations that must be followed regarding these medications.
HealthWarehouse.com, Inc. (HEWA), closed Friday's trading session at $0.20, up 11.11%, on 106,380 volume with 22 trades. The average volume for the last 60 days is 50,992 and the stock's 52-week low/high is $0.07/$0.95.
Plandai Biotechnology, Inc. (PLPL)
Greenbackers, WallstreetSurfers, SmallCapVoice, First Penny Picks, StocksImpossible, and OTCJournal reported earlier on Plandai Biotechnology, Inc. (PLPL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Plandai Biotechnology, Inc. is a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical. The Company and its subsidiaries develop highly bioavailable, phytonutrient rich extracts. These are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology lists on the OTCQB. The Company has its corporate head office in Seattle, Washington. It also has offices in London, England and Nelspruit in the province of Mpumalanga, South Africa.
Plandai Biotechnology, by way of its wholly owned subsidiaries, farms more than 7,500 acres of land in the Mpumalanga province of South Africa. The Company farms a full complement of produce, which it uses in its creation of highly bioavailable extracts, ranging from citrus to avocado pears to more than 2,000 acres of tea.
Plandaí Biotechnology delivers highly bioavailable, phytonutrient rich extracts under the trademark, Phytofare™. Plandaí proprietary plant extracts have shown, in published studies, to have increased bioavailability. The Company believes through its studies that this is between 60-80 percent. This is considerably greater than anything presently available.
The Company’s extracts include but are not limited to, gallate catechins from green tea, (catechin gallate (CG), epigallocatechin gallate (EGCG), gallocatechin gallate (GCG), and epicatechin gallate (ECG); carotenoids (lycopene) from tomatoes, and also citrus bioflavonoids and limonoids. In addition, its gallate catechin extract will be the active ingredient in formulated products supporting weight loss, antiaging, the lowering of blood cholesterol, the regulation of high blood pressure, as well as controlling diabetes 1 and 2.
This week, Plandaí Biotechnology announced that Uruguay's Ministry of Public Health approved an academic collaboration between Plandaí and the Group of Medicinal Chemistry from the School of Science at the University of the Republic in Montevideo, Uruguay. Issued in September 2014, the approval allows Plandaí Biotechnology to grow cannabis in combination with the University, for medical research, which will be undertaken by students and scientists from the School of Science at the University.
Plandaí Biotechnology - Uruguay, SA is a wholly-owned subsidiary of Plandaí Biotechnology. This subsidiary is currently the only company given authorization to grow cannabis and conduct medical research in Uruguay.
Plandai Biotechnology, Inc. (PLPL), closed Friday's trading session at $0.42, even for the day, on 166,207 volume with 87 trades. The average volume for the last 60 days is 192,608 and the stock's 52-week low/high is $0.12/$3.12.
Chancellor Group, Inc. (CHAG)
Real Pennies and SmallCapVoice reported earlier on Chancellor Group, Inc. (CHAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Chancellor Group, Inc.’s chief activities include growing Bitcoin transaction-based mobile app start-ups, companies and other holdings. Additionally, the Company’s activities include the acquisition, exploration, and development of natural gas and oil properties. Chancellor Group also examines opportunities in the fields of Bitcoin mining, advanced mobile apps, advanced software algorithms for entertainment and media.
The Company’s shares trade on the OTC Markets’ OTCQB. Founded in 1986, Chancellor Group is headquartered in Amarillo, Texas. The Company previously went by the name Nighthawk Capital, Inc. It changed its corporate name to Chancellor Group, Inc. in March of 1996.
The Company’s start-ups and holdings include The Fuelist (Data driven valuations), Pimovi, Gryphon Production Co. (Enhanced Innovation), Trademason (Financial Relationship Extraction, Data Mining & Analytics), Koala Pictures, and Chancellor Oil & Natural Gas.
Pimovi offers wearable live and real-time Point Of View (POV) video and personalized content via Mobile Apps; Integrated Bitcoin transaction support for in-app payments including a marketplace for exclusive content; merchandise and products.
This year, Fuelist LLC, a 51 percent-owned subsidiary of The Chancellor Group, launched its pricing and valuation platform. It allows consumers and enterprises to find values and track valuations over time while identifying investment and arbitrage opportunities in the collector car and motorcycle markets.
In late May of this year, Fuelist announced that it received approval from Apple, Inc. for the download of the "Fuelist" collector vehicle valuation mobile app. The design of this app is to target the fast-expanding classic car market. The Fuelist is a mobile and web platform that takes advantage of deep segment expertise and big data analysis tools to value classic vehicles.
The design of the app is to use extensive data collection to pinpoint what price one should realistically pay for a classic vehicle. It combs data from thousands of classic car sales and compiles the findings into a huge database. This database includes location information, sale price, vehicle specifications, as well as detailed overviews.
Chancellor Group, Inc. (CHAG), closed Friday's trading session at $0.0138, up 97.14%, on 38,200 volume with 6 trades. The average volume for the last 60 days is 40,849 and the stock's 52-week low/high is $0.006/$0.1475.
Yew Bio-Pharm Group, Inc. (YEWB)
Greenbackers reported earlier on Yew Bio-Pharm Group, Inc. (YEWB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Yew Bio-Pharm Group, Inc., via its operating entity, Harbin Yew Science and Technology Development Co., Ltd. (HDS), is a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM), and products made from yew timber in China. In 2013, Yew Bio-Pharm became a publicly-traded company in the United States. Founded in 1996, the Company has its headquarters in Xiangfang District, Harbin City, Heilongjiang Province, People’s Republic of China.
Raw material from the species of yew tree that Yew Bio-Pharm grows contains taxol, and TCM containing yew raw materials has received approval as a traditional Chinese medicine in China for the secondary treatment of certain cancers. The Company grows Japanese yew trees (also known in China as Northeast yew trees), taxus cuspidata, on mountain hillsides near Harbin. It cultivates them in four nurseries it operates close to Harbin.
The Company utilizes a patented, accelerated growth technology to hasten the growth and maturity and commercialization of yew trees. It believes that it is one of the few companies possessing a permit to sell them.
The Company’s patented Asexual Reproduction Method speeds up the commercial viability of a yew tree. Consequently, a yew tree can be used for commercialization starting in approximately three years, versus over 50 years for naturally grown yew trees.
Through this method, the Company can more than replenish the number of yew trees it cultivates and puts into production. The Patent is valid through September 29, 2030. The patented Asexual Reproduction Method was developed by Yew Bio-Pharm’s Founder and President, Zhiguo Wang.
Earlier this month, Yew Bio-Pharm announced a multi-year exclusive distribution agreement with Carpal Aid. This is to distribute its non-invasive medical device "Carpal Aid" for carpal tunnel syndrome throughout China. This product was developed to provide functional support and help for hand numbness. Carpal Aid is a single use disposable adhesive strip. This strip creates a bridging action that lifts the skin above the median nerve to relieve pressure. The design of it is to be light-weight and invisible. Carpal Aid promotes restful sleep and it works on both hands.
Furthermore, this week, Yew Bio-Pharm applauded the creation of a subsidy program by the State Forestry Administration of China to promote the development and growth of Chinese medicinal herb crops.
Mr. Zhiguo Wang, Chairman and CEO of Yew Bio-Pharm Group, said, “As a leading yew tree grower in the region, and producer of traditional Chinese medicine used in certain cancer treatments, we are very encouraged by this positive development. The subsidies should help spur development of new projects and incentivize economic growth in the region for growers of traditional Chinese medicine crops."
Yew Bio-Pharm Group, Inc. (YEWB), closed Friday's trading session at $0.42, up 27.20%, on 60,200 volume with 16 trades. The average volume for the last 60 days is 10,904 and the stock's 52-week low/high is $0.111/$1.10.
Gilla, Inc. (GLLA)
SmallCapFinancialWire, TopPennyStockMovers, and Real Pennies reported on Gilla, Inc. (GLLA), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Gilla, Inc. designs, markets, and distributes electronic cigarettes (e-cigarettes) vaporizers, e-liquids, as well as related accessories. E-cigarettes are increasingly being considered as an alternative to conventional tobacco cigarettes. They provide authentic smoking pleasure and do not burn tobacco. Gilla lists on the OTC Markets’ OTCQB and the Company has its headquarters in Florida. It also has an office in Toronto, Ontario.
Gilla has a dual branch business model. One branch is white-label solutions, including branding, marketing and sales support. The other branch is e-commerce solutions such as Charlie's Club, a members-only online e-cigarette monthly subscription service featuring free hardware and no contracts.
E-cigarettes and vaporizers are replacements for traditional cigarettes. E-cigarettes produce no offensive smells or second hand smoke. However, they are not smoking cessation devices. E-cigarettes allow smokers to reproduce the smoking experience.
For this current quarter, Gilla has shipped more than $500,000 in product under its white label business unit. It is attaining its targeted gross margin of between 30-40 percent on these sales.
Mr. Danny Yuranyi, Gilla President, stated "Our white label business unit is now beginning to demonstrate the revenue and profitability potential we believed it could achieve. We now have a very strong client base under multi-year exclusive contracts and we continue to aggressively add to this base."
In addition, this quarter, Gilla launched Charlie's Club. This is an online subscription-based e-cigarette membership (www.charliesclub.com). Charlie's Club is the first online e-cigarette subscription service to provide free hardware and accessories to its members. Charlie's Club subsidizes the costs of the hardware for its members, with no contracts or minimum terms. Furthermore, Charlie's Club has developed a strong affiliate program.
In the U.S., members select one of three membership packages delivering monthly refills based on a member's consumption preferences. The membership packages are: Silver (15 cartridges/month), Gold (25 cartridges/month), and Platinum (50 cartridges/month).
Gilla, Inc. (GLLA), closed Friday's trading session at $0.20, up 42.86%, on 226,012 volume with 18 trades. The average volume for the last 60 days is 44,183 and the stock's 52-week low/high is $0.02/$0.35.
Sibling Group Holdings, Inc. (SIBE)
The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.22, up 16.40%, on 307,161 volume with 51 trades. The stock’s average daily volume over the past 60 days is 34,846, and its 52-week low/high is $0.04/$0.24.
Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.
Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.
Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.
IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer
Sibling Group Holdings, Inc. Company Blog
Sibling Group Holdings, Inc. News:
Sibling Group to Acquire Urban Planet Mobile™ -- Leading Global Innovator of Educational Products
LoudCloud Systems Adds Content Partner Blended Schools Network to K-12 Offerings
Sibling's Blended Schools Network and LoudCloud Team Up to Accelerate Online Learning
Ecrypt Technologies, Inc. (ECRY)
The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.115, up 4.55%, on 21,050 volume with 6 trades. The stock’s average daily volume over the past 60 days is 9,753 and its 52-week low/high is $0.09/$0.179.
Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.
Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.
The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.
Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer
Ecrypt Technologies, Inc. Blog
Ecrypt Technologies, Inc. News:
Ecrypt Technologies, Inc. Appoints Urvashi Mehra as VP of Global Healthcare Solutions
Ecrypt Technologies Inc.'s Chief Executive Officer, Dr. Thomas A. Cellucci, is the First American Elected to EECSA's Board
Safe America Appoints Ecrypt CEO to Head Drive
Boreal Water Collection, Inc. (BRWC)
The QualityStocks Daily Newsletter would like to spotlight Boreal Water Collection, Inc. (BRWC). Today, Boreal Water Collection, Inc. closed trading at $0.0116, up 0.87%, on 2,523,467 volume with 9 trades. The stock’s average daily volume over the past 60 days is 832,603, and its 52-week low/high is $0.0032/$0.03.
Boreal Water Collection, Inc. (BRWC) is an established water bottler of premium private-labeled bottled water products tailored for each client’s particular need, be it publicity, promotion, marketing, internal use or a specific event. This emphasis on customization and quality has earned Boreal an impressive reputation, evidenced by its prestigious customer base of high-end beverage brands, retailer channels, high-end hotels and restaurant chains such as H&M, Mercedes, W Hotels, Dean & Deluca, Fred Water, Wat-aah, Saks Fifth Ave, Balance Water, NY Quin Hotel, Bouchon Bakery and Princeton University, just to name a few!
Located 90 miles north New York City, Boreal’s plant is only 17 miles from its well-protected source of natural spring water, a pristine and abundant spring source deep inside the heart of the Catskill Mountains. The spring’s exceptional geological and geographical features have created the perfect environment for Boreal’s low-mineral, sodium-free and well-balanced PH water. With exclusive exploitation rights, Boreal has a confirmed volume in excess of thousands of millions of gallons.
Boreal offers a line of award-winning water products, including functional enhanced water, infused water, carbonated water, vitamins enhanced water, flavored still or sparkling, minerals enhanced water, oxygenated water, electrolyte water, distilled water, alkaline water, caffeinated water and natural spring water.
Accommodating this plentiful water supply and range of product offerings, Boreal has established a 75,000-square foot manufacturing facility. Boreal can process a full range of water and bottle types and has the most creative staff for all private labeling needs. The company offers fully integrated turnkey service, made-to-order labeling along with distinctive water bottles. In short, Boreal is a “Boutique Bottler” and is focusing on becoming the leader of this attractive niche of the growing multi-billion dollar bottled water industry. Disclaimer
Boreal Water Collection, Inc. Company Blog
Boreal Water Collection, Inc. News:
Boreal Water Collection, Inc. Announces Engagement of QualityStocks Investor Relations Services
H&M Group (Manhattan) Signs With Boreal Water Collection
Boreal Water Collection Signs With Plaza del Sol on Fisher Island Miami, Florida
Oriens Travel and Hotel Management Corp. (OTHM)
The QualityStocks Daily Newsletter would like to spotlight Oriens Travel and Hotel Management Corp. (OTHM). Today, Oriens Travel and Hotel Management Corp. closed trading at $0.0002, even for the day, on 2,100,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 24,449,137, and its 52-week low/high is $0.0001/$0.002.
Oriens Travel and Hotel Management Corp. (OTHM) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Oriens has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Oriens Travel and Hotel Management Corp. Company Blog
Oriens Travel and Hotel Management Corp. News:
Oriens and E-Net Kick Off Second Revenue Initiative
Oriens & E-Net; the Next Steps
Oriens and E-Net Initiate Revenue Plan
Pan Global Corp. (PGLO)
The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.02, even for the day, on 138,150 volume with 5 trades. The stock’s average daily volume over the past 60 days is 522,314, and its 52-week low/high is $0.009/$0.96.
Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.
The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.
Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.
Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer
Pan Global Corp. Company Blog
Pan Global Corp. News:
Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India
Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0593, off by 2.79%, on 46,625 volume with 17 trades. The stock’s average daily volume over the past 60 days is 162,914, and its 52-week low/high is $0.038/$2.00.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program
Cannabics Pharmaceuticals, Inc. (CNBX)
The QualityStocks Daily Newsletter would like to spotlight Cannabics Pharmaceuticals, Inc. (CNBX). Today, Cannabics Pharmaceuticals, Inc. closed trading at $0.28, off by 6.67%, on 3,900 volume with 3 trades. The stock’s average daily volume over the past 60 days is 8,159, and its 52-week low/high is $0.03/$1.40.
Cannabics Pharmaceuticals, Inc. (CNBX) was founded in 2012 by a team of experts in the fields of molecular biology, cancer research and pharmacology, who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant.
Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR, contains a pure concentrate of cannabinoids derived from select cannabis strains, embedded in a sophisticated formulation which provides beneficial therapeutic effects for 10-12 hours upon a single oral administration.
The excipients of the proprietary Cannabics SR formulation are all certified food-grade ingredients and are free of artificial additives or chemical substances. Cannabics’ proprietary technologies are developed in certified laboratories and are licensed to certified manufacturers and distributors with adequate licenses in their local territories. Cannabics Pharmaceuticals itself does not manufacture, distribute, dispense or possess any controlled substances, including cannabis and cannabis-based preparations.
Co-founders Dr. Zohar Koren (CEO) and Dr. Eyal Ballan (CTO) guide the company’s operations with vast experience in business and pharmaceutical development, strategic consulting, venture capital, evolutionary and environmental sciences, anti-cancer drug development and molecular biology. Under their leadership, Cannabics Pharmaceuticals continues to develop its genetic and phenotipic database to provide superior treatments for incapacitating ailments for which there is no cure. Disclaimer
Cannabics Pharmaceuticals, Inc. Company Blog
Cannabics Pharmaceuticals, Inc. News:
Cannabics Pharmaceuticals, Inc. (CNBX) Receives Cannabinoid R&D Lab Certification in Israel
Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR
Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board
Today's Top 3
Penny Stock Mobsters
Wall Street Resources
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Alliance Creative Group (ACGX) Has Been Awarded Additional Printing and Packaging Business From John Paul Mitchell Systems for Their PM Shines Line
- Armco Metals Holdings, Inc. (AMCO) Enters Into an Agreement With a Chile Supplier for Woodchips Purchase
- Boreal Water Collection, Inc. (BRWC) Announces Engagement of QualityStocks Investor Relations Services
- Cannabics Pharmaceuticals, Inc. (CNBX) Receives Cannabinoid R&D Lab Certification in Israel
- Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) and Delphi Sign MOU
- Ecrypt Technologies, Inc. (ECRY) Appoints Urvashi Mehra as VP of Global Healthcare Solutions
- Falcon Crest Energy (FCEN) Names Michael Cvetanovic to Advisory Council
- Infinite Group, Inc. (IMCI) Announces Exclusive Government Channel Partner Agreement for Content Management Tools
- Intelligent Highway Solutions, Inc. (IHSI) Announces Agreement With a Washington D.C. Based Government Relations Firm
- Mobile Lads Corp. (MOBO) Acquires Innovative Online Coupon Platform, CouBox
- One World Holdings, Inc. (OWOO) The One World Doll Project Announces Financing Relationship With New York Hedge Fund, Blackbridge Capital
- Oriens Travel and Hotel Management Corp. (OTHM) and E-Net Kick Off Second Revenue Initiative
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Sibling Group Holdings, Inc. (SIBE) to Acquire Urban Planet Mobile™ -- Leading Global Innovator of Educational Products
- Rejuvel Int'l, Inc. Will Have its Products Included in Celebrity Gift Bags at the 15th Annual Latin GRAMMY® Awards Show at the MGM Grand in Las Vegas
- VistaGen Therapeutics, Inc. (VSTA) Announces Reverse Stock Split
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) the Sale of Exclusive Rights to Legal Enterprise Solutions to Private Equity Group
- WRIT Media Group, Inc. (WRIT) Retro Infinity Sponsors NASCAR Driver Carlos Contreras' Record-Breaking 99th Career Race
- Zenosense, Inc. (ZENO) Protocol Design -- Lung Cancer Detection Tests